Lv62
2680 积分 2023-09-12 加入
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D
5天前
已完结
Incidence of community-acquired pneumonia in urban China: A national population-based study
8天前
已完结
A multivalent RSV vaccine based on the modified vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a phase 3 clinical study
1个月前
已完结
A multivalent RSV vaccine based on the modified vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a phase 3 clinical study
1个月前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
1个月前
已完结
Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial
1个月前
已完结
[Expert consensus on preventive strategies for human papillomavirus-associated diseases in males]
2个月前
已完结
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells
3个月前
已完结
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells
3个月前
已完结
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial
4个月前
已完结
皖公网安备34019202002308
